Genetic variability of vascular endothelial growth factor and prognosis of head and neck cancer in a Brazilian population
Open Access
- 1 February 2010
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 43 (2) , 127-133
Abstract
Vascular endothelial growth factor (VEGF) is one of the most potent endothelial cell mitogens and plays a critical role in angiogenesis. Polymorphisms in this gene have been evaluated in patients with several types of cancer. The objectives of this study were to determine if there was an association of the -1154G/A polymorphism of the VEGF gene with head and neck cancer and the interaction of this polymorphism with lifestyle and demographic factors. Additionally, the distribution of the VEGF genotype was investigated with respect to the clinicopathological features of head and neck cancer patients. The study included 100 patients with histopathological diagnosis of head and neck squamous cell carcinoma. Patients with treated tumors were excluded. A total of 176 individuals 40 years or older were included in the control group and individuals with a family history of neoplasias were excluded. Analysis was performed after extraction of genomic DNA using the real-time PCR technique. No statistically significant differences between allelic and genotype frequencies of -1154G/A VEGF polymorphism were identified between healthy individuals and patients. The real-time PCR analyses showed a G allele frequency of 0.72 and 0.74 for patients and the control group, respectively. The A allele showed a frequency of 0.28 for head and neck cancer patients and 0.26 for the control group. However, analysis of the clinicopathological features showed a decreased frequency of the A allele polymorphism in patients with advanced (T3 and T4) tumors (OR = 0.36; 95%CI = 0.14-0.93; P = 0.0345). The -1154A allele of the VEGF gene may decrease the risk of tumor growth and be a possible biomarker for head and neck cancer. This polymorphism is associated with increased VEGF production and may have a prognostic importance.Keywords
This publication has 34 references indexed in Scilit:
- Functional vascular endothelial growth factor −2578 C/A polymorphism in relation to nasopharyngeal carcinoma risk and tumor progressionClinica Chimica Acta, 2008
- Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with gastric cancerAnnals of Oncology, 2007
- Association of VEGF genetic polymorphisms with prostate carcinoma risk and clinical outcomeCytokine, 2006
- Molecular biology of squamous cell carcinoma of the head and neckJournal of Clinical Pathology, 2006
- Prognostic Value of Vascular Endothelial Growth Factor Tumor Tissue Content of Colorectal CancerOncology, 2005
- Association of Genetic Polymorphisms in the VEGF Gene with Breast Cancer SurvivalCancer Research, 2005
- Vascular endothelial growth factor gene-460 C/T polymorphism is a biomarker for oral cancerOral Oncology, 2005
- VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancerLung Cancer, 2004
- A functional association study of VEGF gene promoter polymorphisms with VEGF expression by stimulated pbm cellsHuman Immunology, 2003
- Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumour development in cutaneous malignant melanomaGenes & Immunity, 2002